Prot# 27646: A Randomised, Double-Blind, Placebo-Controlled, Multicentre Prospective Dose-Finding Phase II/III Study with Atacicept Given Subcutaneously to Subjects Having Recently Experienced a Flare of Systemic Lupus Erythematosus (SLE)

Project: Research project

Project Details

StatusFinished
Effective start/end date5/13/085/13/11

Funding

  • EMD Serono, Inc. (27646)